Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kewaunee Scientific (KEQU) Equity Average (2016 - 2026)

Kewaunee Scientific has reported Equity Average over the past 16 years, most recently at $71.2 million for Q1 2026.

  • Quarterly results put Equity Average at $71.2 million for Q1 2026, up 18.52% from a year ago — trailing twelve months through Jan 2026 was $71.2 million (up 18.52% YoY), and the annual figure for FY2025 was $59.6 million, up 29.35%.
  • Equity Average for Q1 2026 was $71.2 million at Kewaunee Scientific, up from $68.5 million in the prior quarter.
  • Over the last five years, Equity Average for KEQU hit a ceiling of $71.2 million in Q1 2026 and a floor of $34.5 million in Q4 2022.
  • Median Equity Average over the past 5 years was $43.1 million (2024), compared with a mean of $48.6 million.
  • Biggest five-year swings in Equity Average: fell 13.43% in 2022 and later surged 44.18% in 2024.
  • Kewaunee Scientific's Equity Average stood at $34.5 million in 2022, then increased by 18.02% to $40.8 million in 2023, then skyrocketed by 41.47% to $57.7 million in 2024, then rose by 18.71% to $68.5 million in 2025, then grew by 3.98% to $71.2 million in 2026.
  • The last three reported values for Equity Average were $71.2 million (Q1 2026), $68.5 million (Q4 2025), and $65.8 million (Q3 2025) per Business Quant data.